1
Clinical Trials associated with Chronic lymphocytic leukaemia vaccine (XEME Biopharma)NU 13H05: A Phase Ib Trial of Oncoquest-CLL Vaccine for Treatment-Naive Patients With Chronic Lymphocytic Leukemia
This Phase I trial studies the safety and efficacy of vaccine therapy in treating patients with previously untreated chronic lymphocytic leukemia. Liposome-based vaccines containing an extract of a person's cancer cells and the immunostimulant interleukin-2 may help the body to build an effective immune response to kill cancer cells.
100 Clinical Results associated with Chronic lymphocytic leukaemia vaccine (XEME Biopharma)
100 Translational Medicine associated with Chronic lymphocytic leukaemia vaccine (XEME Biopharma)
100 Patents (Medical) associated with Chronic lymphocytic leukaemia vaccine (XEME Biopharma)
100 Deals associated with Chronic lymphocytic leukaemia vaccine (XEME Biopharma)